ClinicalTrials HQ

Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients.

Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients.

Active, not recruiting · NCT01442246 · Registry updated 2024-09-19
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients.Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasmActive, not recruitingPhase 32024-09-19NCT01442246

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Astellas Pharma Inc43
UNICANCER111

35 results · Page 1 of 2

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Hopsitalier Prive - Polyclinique Du LittoralSaint-BrieucFrance1
Centre Hospitalier DepartementalLa Roche-sur-YonFrance1
Chru de BrestBrestFrance1
CHRU LilleLilleFrance17
CHU BesanconBesançonFrance6
Chu BocageDijonFrance2
Chu Bordeaux- Hopital PellegrinBordeauxFrance1
Chu CaremeauNîmesFrance3
CHU de NancyNancyFrance2
Chu La MiletriePoitiersFrance1
Chu LimogesLimogesFrance24
Chu NantesNantesFrance45
Chu PasteurNiceFrance1
CHU PontchaillouRennesFrance8
CHU RangueilToulouseFrance23
Chu StrasbourgStrasbourgFrance1
Clinique BeausoleilMontpellierFrance2
Clinique MutualisteSaint-EtienneFrance1
Clinique Victor PauchetAmiensFrance1
HEGPParisFrance5
Hopital Charles NicolleRouenFrance6
Hopital CochinParisFrance20
Hopital Edouard HerriotLyonFrance5
Hopital FochSuresnesFrance17
Hopital Henri MondorCréteilFrance23